Parkwood LLC’s Connect Biopharma Holdings CNTB Stock Holding History

Parkwood LLC’s Portfolio CNTB Stock Details CNTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,469	Closed	-$375K	–	121
2021 Q3	$375K	Buy	+15,469	New	+$350K	0.05%	106

Other funds holding CNTB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Parkwood LLC's CNTB Position: Q4 2021 in Review

Parkwood LLC sold out of Connect Biopharma Holdings (CNTB) in Q4 2021, closing a stake of 15,469 shares — an estimated $375K sold.

Parkwood LLC first reported a position in CNTB in Q3 2021 and held it in 1 quarter. The position peaked at $375K in Q3 2021. 29 funds tracked by Wall St. Rank hold CNTB as of Q4 2021.

Parkwood LLC reported no remaining Connect Biopharma Holdings position as of Q4 2021 after selling out during the quarter.
Parkwood LLC sold 15,469 Connect Biopharma Holdings shares in Q4 2021, an estimated $375K.
Parkwood LLC first reported a position in Connect Biopharma Holdings in Q3 2021 and held it in 1 quarter.
Parkwood LLC's Connect Biopharma Holdings position peaked at $375K in Q3 2021.
29 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q4 2021.

Based on Parkwood LLC's 13F filing for Q4 2021, filed 11 Feb 2022.